Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study

Summary

Knowledge, acceptability and perception of paediatric schistosomiasis and its treatment will be explored through a social science-driven mixed-methods approach within three endemic countries: Kenya, Uganda and Côte d'Ivoire.

Conditions

• Schistosomiasis in Children
• Social Acceptance

Interventions

BEHAVIORAL

Community pilot L-PZQ distribution - intervention is NOT part of this observational study

Data collection will occur at two main time points of the ADOPT-community intervention project: before (baseline assessment) and during/after the community pilot L-PZQ distribution, in order to inform the design and process of the implementation, including that of advocacy and mobilisation, of Levo-Praziquantel delivery to PSAC.

Sponsors & Collaborators

• African Institute for Health and Development

  collaborator UNKNOWN

• Makerere University

  collaborator OTHER

• European and Developing Countries Clinical Trials Partnership (EDCTP)

  collaborator OTHER_GOV

• Global Health Innovative Technology Fund

  collaborator OTHER

• Stichting Lygature

  collaborator UNKNOWN

• Université Félix Houphouët-Boigny

  collaborator UNKNOWN

• Kenya Medical Research Institute

  collaborator OTHER

• Swiss Tropical & Public Health Institute

  collaborator OTHER

• SCI Foundation

  collaborator UNKNOWN

• Technical University of Munich

  lead OTHER

Principal Investigators

• Mary Nyamongo, Dr. · African Institute for Health and Development

• Stella Neema, Prof. · Makerere University - Social Science Department

• Alain Toh, Prof. · Université Félix Houphouët-Boigny d'Abidjan-Cocody

Eligibility

Min Age

18 Years

Max Age

99 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-12-01

Primary Completion

2025-03-31

Completion

2025-12-31

Countries

• Côte d’Ivoire
• Kenya
• Uganda

Study Locations